133 related articles for article (PubMed ID: 18432364)
1. [Concurrent lymphoproliferative and myeloproliferative disorders in three patients].
Hernández Sánchez MC; García Quiroga H; Ulibarrena Redondo C; Méndez Sánchez JA
An Med Interna; 2008 Feb; 25(2):78-80. PubMed ID: 18432364
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases.
Manoharan A; Catovsky D; Clein P; Traub NE; Costello C; O'Brien M; Boralessa H; Galton DA
Br J Haematol; 1981 May; 48(1):111-6. PubMed ID: 6941808
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous occurrence of polycythemia vera and Waldenstrom macroglobulinemia: a case report and review of the literature.
Saba NF; Warth JA; Ross DG
Haematologia (Budap); 2002; 32(1):17-23. PubMed ID: 12243551
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases.
Xiao JC; Walz-Mattmüller R; Ruck P; Horny HP; Kaiserling E
Gen Diagn Pathol; 1997 Feb; 142(3-4):147-53. PubMed ID: 9065578
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review.
Marchetti M; Carobbio A; Capitoni E; Barbui T
Am J Hematol; 2018 May; 93(5):698-703. PubMed ID: 29377227
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.
Dührsen U; Augener W; Zwingers T; Brittinger G
Br J Haematol; 1987 Oct; 67(2):235-9. PubMed ID: 3499930
[TBL] [Abstract][Full Text] [Related]
8. Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disorders.
Kesteven PJ; Pullan JM; Glass UH; Wetherley-Mein G
Clin Lab Haematol; 1985; 7(4):297-306. PubMed ID: 3830529
[TBL] [Abstract][Full Text] [Related]
9. The association of thyrotoxicosis and chronic lymphoproliferative disorders.
Paydas S; Sahin B; Hazar B; Yavuz S
Leuk Lymphoma; 2000 Jun; 38(1-2):131-5. PubMed ID: 10811455
[TBL] [Abstract][Full Text] [Related]
10. Myeloproliferative and lymphoproliferative disorders in the same patient.
Iland H; Chan W; Vincent PC
Aust N Z J Med; 1980 Dec; 10(6):650-3. PubMed ID: 6938186
[TBL] [Abstract][Full Text] [Related]
11. Association of myeloproliferative and lymphoproliferative disorders.
Gaillard JB; Carillo S; Henry L; Jourdan E; Lavabre-Bertrand T
Clin Adv Hematol Oncol; 2012 Nov; 10(11):756-7. PubMed ID: 23271265
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.
Todisco G; Manshouri T; Verstovsek S; Masarova L; Pierce SA; Keating MJ; Estrov Z
Leuk Lymphoma; 2016 May; 57(5):1054-9. PubMed ID: 26402369
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
Jakó J; Szerafin L
Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
Wehmeier A; Daum I; Jamin H; Schneider W
Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
[TBL] [Abstract][Full Text] [Related]
17. [Clinical picture of tuberculosis with concomitant hemoblastoses].
Iuldasheva NE; Karachunskiĭ MA; Pivnik AV
Ter Arkh; 2004; 76(3):49-51. PubMed ID: 15108459
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
[TBL] [Abstract][Full Text] [Related]
19. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
[TBL] [Abstract][Full Text] [Related]
20. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
Zhang B; Lewis SM
Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
